Cargando…

Time course transcriptome data analysis for in vitro modeling of dilated cardiomyopathy using patient-derived induced pluripotent stem cells

Detalles Bibliográficos
Autores principales:	Li, Xing, Wyles, Saranya, Hrstka, Sybil C, Kocher, Jean-Pierre A, Terzic, Andre, Olson, Timothy M, Nelson, Timothy J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625215/ http://dx.doi.org/10.1186/1471-2105-16-S15-P8

Ejemplares similares

Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient‐Derived iPSC Model
por: Wyles, SP, et al.
Publicado: (2016)

Prioritizing disease-related genes and pathways by integrating patient-specific iPSC-derived RNA-seq and whole genome sequencing in hypoplastic left heart syndrome
por: Li, Xing, et al.
Publicado: (2014)

Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009)

Mechanical Dyssynchrony Precedes QRS Widening in ATP‐Sensitive K(+) Channel–Deficient Dilated Cardiomyopathy
por: Yamada, Satsuki, et al.
Publicado: (2013)

Right ventricular function in dilated cardiomyopathy: relation to location of focal myocardial fibrosis
por: Abdelrazek, Mohamed A, et al.
Publicado: (2013)

Mechanical effects of midwall fibrosis in non-ischemic dilated cardiomyopathy
por: Taylor, Robin J, et al.
Publicado: (2014)

Left ventricular hemodynamic forces are altered in patients with dilated cardiomyopathy
por: Eriksson, Jonatan, et al.
Publicado: (2015)

Evaluation of CMR predictors of right ventricular remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Left atrial volume is associated with mid-wall fibrosis in Dilated Cardiomyopathy
por: Fanaie, Fariba, et al.
Publicado: (2011)

Potential value of T1 mapping in dilated cardiomyopathy and correlation with circumferential strain
por: Jacquier, Alexis, et al.
Publicado: (2013)

Systems biology surveillance decrypts pathological transcriptome remodeling
por: Faustino, Randolph S., et al.
Publicado: (2015)

Potential value of T1 mapping in cardiac MR assessment of hypertrophic cardiomyopathy and dilated cardiomyopathy patients: preliminary results
por: Jacquier, Alexis, et al.
Publicado: (2012)

Myocardial fibrosis is not associated with reduced quality of life in patients with dilated or hypertrophic cardiomyopathy
por: Khan, Razi, et al.
Publicado: (2011)

Association of LA volumes and mid-wall myocardial fibrosis in the Dilated cardiomyopathy patients
por: Fanaie, Fariba, et al.
Publicado: (2011)

Characterization of dilated cardiomyopathy using tissue phase mapping and extracellular volume measurement
por: Sommerville, Lewis C, et al.
Publicado: (2013)

7T versus 3T phosphorous magnetic resonance spectroscopy in patients with dilated cardiomyopathy
por: Stoll, Victoria, et al.
Publicado: (2015)

Diffuse fibrosis in dilated cardiomyopathy results in a shorter myocardial null time
por: Han, Yuchi, et al.
Publicado: (2009)

Comparison of myocardial mechanical properties in patients with dilated cardiomyopathy with and without acute heart failure
por: Choudhary, Naila, et al.
Publicado: (2014)

Regional diffuse fibrosis and strain characteristics differ between children with hypertrophic and dilated cardiomyopathy
por: Patel, Jyoti K, et al.
Publicado: (2015)

Parameters of Right Ventricle as etiological distinction between ischemic and non-ischemic dilated cardiomyopathy
por: Gomes, Hélder Andrade, et al.
Publicado: (2015)

Impact of left ventricular late enhancement on pulmonary arterial hypertension in idiopathic dilated cardiomyopathy
por: Pérez-David, Esther, et al.
Publicado: (2015)

Genomes or exomes: evaluation of cost, time and coverage
por: Middha, Sumit, et al.
Publicado: (2011)

Myocardial fibrosis is a predictor of atrial fibrillation in dilated cardiomyopathy. Role of cardiovascular magnetic resonance
por: Almeida, Ana G, et al.
Publicado: (2011)

Exercise training improves cardiac function, quality of life and exercise capacity in patients with dilated cardiomyopathy
por: Holloway, Cameron J, et al.
Publicado: (2011)

Changes in levels of BNP, CRP and leukocyte formula during exercise testing in patients with dilated cardiomyopathy
por: Peric, V, et al.
Publicado: (2013)

Utility of Native T1 mapping to differentiate between athlete's heart and non-ischemic dilated cardiomyopathy
por: Mordi, Ify, et al.
Publicado: (2015)

CMRI morphological and functional changes of the heart in myocarditis and dilated cardiomyopathy in acute pediatric heart failure
por: Kharabish, Ahmed E
Publicado: (2016)

The decisive role of cardiovascular MRI delayed hyperenhancement (DHE) pattern for risk stratification for dilated cardiomyopathy
por: Venero, Jose V, et al.
Publicado: (2009)

Can cardiac MRI be the index metric for risk stratification in dilated cardiomyopathy; the impact of an LV mid-myocardial stripe on subsequent risk of LVAD, transplantation and death
por: Venero, Jose, et al.
Publicado: (2012)

Cardiac Magnetic Resonance for evaluating early outcomes of stem cell therapy in non-ischemic dilated cardiomyopathy
por: Gulati, Gurpreet S, et al.
Publicado: (2011)

Bio-imaging: late gadolinium enhancement in dilated cardiomyopathy and its relation to novel biomarkers of fibrosis and remodeling
por: Abdel-Aty, Hassan, et al.
Publicado: (2013)

Clinical and echocardiographic differences in patients with dilated cardiomyopathy in the frame depending preserved left ventricular contractile reserve
por: Peric, V, et al.
Publicado: (2013)

Epicardial adipose tissue evaluated with cardiac magnetic resonance in normal subject and in patients with ischemic and dilated cardiomyopathies
por: Secchi, Francesco, et al.
Publicado: (2016)

Prognostic value of late enhancement in cardiac magnetic resonance in patients with dilated cardiomyopathy: a meta-analysis
por: Secchi, Francesco, et al.
Publicado: (2016)

Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS Cardiomyopathy
por: Yamada, Satsuki, et al.
Publicado: (2015)

Differences in virus prevalence and load in the hearts of patients with chronic dilated cardiomyopathy with and without immune-mediated inflammatory disease
por: Dennert, R, et al.
Publicado: (2010)

Feature tracking cardiac magnetic resonance imaging for the evaluation of myocardial strain in patients with dilated cardiomyopathy and in healthy controls
por: Breuninger, Kristin, et al.
Publicado: (2013)

Diffuse myocardial fibrosis in early forms of dilated cardiomyopathy: insights from T1 mapping cardiovascular magnetic resonance
por: aus dem Siepen, Fabian, et al.
Publicado: (2013)

Predicting mortality in patients with non-ischemic dilative cardiomyopathy: Potential of extracellular volume imaging by cardiovascular magnetic resonance
por: Koopmann, Katharina, et al.
Publicado: (2014)

Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects
por: Im, Dong Jin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0igr1g9bubpts54k1eq31t1v8j